SAN FRANCISCO, July 25, 2017 -- Hagens Berman Sobol Shapiro LLP reminds investors in FleetCor Technologies, Inc. (NYSE:FLT) of the August 14, 2017 Lead Plaintiff deadline in the pending securities class action.
If you purchased or otherwise acquired securities of FLT between February 5, 2016 and May 2, 2017 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/FLT
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing [email protected].
On March 1, 2017, Capital Forum reported in part that FleetCor’s business model improperly relies on overcharging customers and padding fee income through late fees even when customers pay on time. This news drove the price of FleetCor shares down approximately 3% to close at $164.75 that day.
On April 4, 2017, Citron Research published a report, similarly based on customer, competitor and former employee interviews, accusing Fleetcor of being a “predatory company by design, whose core strategy is to methodically rip off its customers, using business practices and fees that are designed to deceive.” This news drove the price of FleetCor shares down approximately 6% to close at $141.60 that day.
On April 27, 2017, Citron Research issued a follow-up report explaining how FleetCor developed a scheme to categorize customers based on the level of improper fees that could be charged without the customers complaining. This news drove the price of FleetCor shares down approximately 4% to close at $145.65 that day.
On May 1, 2017, Chevron sued FleetCor for breach of contract. This news drove the price of FleetCor shares down approximately 7% to close at $138.00 on May 2, 2017.
When, on May 3, 2017, Citron Research reported on Chevron’s lawsuit the price of FleetCor shares fell approximately 5% to close at $131.26 that day.
On May 3, 3017, Citron and Benzinga reported on the filing of Chevron’s lawsuit. This news drove the price of FleetCor shares down approximately 5% to close at $131.26 on May 3, 2017.
“We’re focused on events as they unfold and certainly on Company’s reported business practices that, if true, appear to contradict earlier statements to investors,” said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding FleetCor should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000


Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Italy Fines Apple €98.6 Million Over App Store Dominance
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 



